STEVEN G. LITCHFIELD - 20 Aug 2023 Form 4 Insider Report for MAXLINEAR, INC (MXL)

Role
Chief Financial Officer and Chief Corporate Strategy Officer
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol
MXL
Transactions as of
20 Aug 2023
Transactions value $
$0
Form type
4
Filing time
22 Aug 2023, 19:30:05 UTC
Previous filing
23 May 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Award $0 +1.26K +0.35% $0.00 363K 20 Aug 2023 Direct F1
transaction MXL Common Stock Award $0 +1.66K +0.46% $0.00 365K 20 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the performance period ended July 2023 that were approved as part of the 2022 performance-based restricted stock award granted on July 29, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Performance-Based Restricted Stock Unit Election Form entered into by the Reporting Person on September 15, 2022 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.

Remarks:

Chief Financial Officer and Chief Corporate Strategy Officer